<?xml version="1.0" encoding="UTF-8"?>
<!-- Generator: Adobe Illustrator 16.0.0, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg version="1.1" id="Capa_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" width="893px" height="679.5px" viewBox="0 0 893 679.5" enable-background="new 0 0 893 679.5" xml:space="preserve">
<rect y="186.219" opacity="0.4" fill="#D7AE1A" width="893" height="60.953"/>
<rect x="23.277" y="-9.553" fill="none" width="438.723" height="43.341"/>
<text class="title" transform="matrix(1 0 0 1 24.9585 38.7676)" fill="#1D1D1B" font-family="Robot" font-weight="700" font-size="30">Principales vacunas candidatas contra el zika</text>
<path d="M72.018,205.271"/>
<rect y="54.73" opacity="0.7" fill="#D7AE1A" width="893" height="56"/>
<text transform="matrix(1 0 0 1 49 88.416)" font-family="Robot" font-weight="700" font-size="14">Institution/company</text>
<text transform="matrix(1 0 0 1 272.5161 88.749)" font-family="Robot" font-weight="700" font-size="14">Country</text>
<text transform="matrix(1 0 0 1 396 87.6152)" font-family="Robot" font-weight="700" font-size="14">Therapeutic approach</text>
<text transform="matrix(1 0 0 1 675 88.749)" font-family="Robot" font-weight="700" font-size="14">Phase of development</text>
<text class="r1" transform="matrix(1 0 0 1 48.9995 146.4092)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">National Institute of Alergy </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">and Infectious Diseases</tspan>
</text>
<text class="r1" transform="matrix(1 0 0 1 272.5161 153.0088)" font-family="Robot" font-size="11">USA</text>
<text class="r1" textLength="800" transform="matrix(1 0 0 1 396 126.6094)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Dos candidatos:</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-DNA vaccine based on the West</tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">Nile virus vaccine model</tspan>
  <tspan x="0" y="39.6" font-family="Robot" font-size="11">-Live attenuated virus vaccine, based </tspan>
  <tspan x="0" y="52.8" font-family="Robot" font-size="11">on the Dengue virus vaccine model </tspan>
</text>
<text class="r1" transform="matrix(1 0 0 1 675 153.0088)" font-family="Robot" font-size="11">Preclinical (in animals)</text>
<text class="r6" transform="matrix(1 0 0 1 675 465.625)" font-family="Robot" font-size="11">Preclinical</text>
<text class="r3" transform="matrix(1 0 0 1 675 278.1865)" font-family="Robot" font-size="11">Preclinical</text>
<text class="r2" transform="matrix(1 0 0 1 48.9995 219.9102)" font-family="Robot" font-size="11">Butantan Institute (Sao Paolo)</text>
<text class="r2" transform="matrix(1 0 0 1 272.5161 219.9102)" font-family="Robot" font-size="11">Brazil</text>
<text class="r2" transform="matrix(1 0 0 1 396 200.1104)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Two candidates:</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-Inactivated virus vaccine</tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">-Live attenuated virus vaccine</tspan>
  <tspan x="0" y="39.6" font-family="Robot" font-size="11">in collaboration with the NIH, USA</tspan>
</text>
<text class="r2" transform="matrix(1 0 0 1 675 219.9102)" font-family="Robot" font-size="11">Virus culture</text>
<rect y="627.594" opacity="0.7" fill="#D7AE1A" width="893" height="4"/>
<rect y="391.521" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect x="1" y="484.297" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect x="9.565" y="788.68" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect y="579.905" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<rect y="296.352" opacity="0.4" fill="#D7AE1A" width="893" height="47.457"/>
<text class="r3" transform="matrix(1 0 0 1 48.999 278.1865)" font-family="Robot" font-size="11">Jenner Institute (Oxford)</text>
<text class="r3" transform="matrix(1 0 0 1 272.5161 278.1865)" font-family="Robot" font-size="11">Great Britain</text>
<text class="r3" textLength="400" transform="matrix(1 0 0 1 396 271.5869)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Non-replicative adenovirus expressing </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">Zika virus surface proteins</tspan>
</text>
<text class="r4" transform="matrix(1 0 0 1 48.9985 323.2939)" font-family="Robot" font-size="11">Bharat BioTech (Hyderabad)</text>
<text class="r4" transform="matrix(1 0 0 1 272.5161 323.2939)" font-family="Robot" font-size="11">India</text>
<text class="r4" transform="matrix(1 0 0 1 675 323.2949)" font-family="Robot" font-size="11">Preclinical studies</text>
<text class="r4" textLength="500" transform="matrix(1 0 0 1 396 310.0947)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Two candidates:</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-Inactivated virus vaccine</tspan>
  <tspan x="0" y="26.399" font-family="Robot" font-size="11">-Recombinant vaccine with viral surface proteins</tspan>
</text>
<text class="r5" transform="matrix(1 0 0 1 48.998 358.0859)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Inovio Pharmaceuticals </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">(Pennsylvania) </tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">GeneOne Life Science (Seoul)</tspan>
</text>
<text class="r5" transform="matrix(1 0 0 1 272.5161 364.6865)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">USA</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">South Korea</tspan>
</text>
<text class="r5" textLength="400" transform="matrix(1 0 0 1 396 364.6855)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">DNA vaccines that code for capsid </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">and surface viral proteins</tspan>
</text>
<text class="r5" textLength="550" transform="matrix(1 0 0 1 675 358.0859)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">-In preclinical studies since 3T 2015</tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">-Phase I clinical studies (in humans) </tspan>
  <tspan x="0" y="26.4" font-family="Robot" font-size="11">planned for 4T 2016</tspan>
</text>
<text class="r10" transform="matrix(1 0 0 1 48.998 418.4648)" font-family="Robot" font-size="11">Sanofi Pasteur (Lyon)</text>
<text class="r6" transform="matrix(1 0 0 1 48.998 465.625)" font-family="Robot" font-size="11">Hawaii Biotech (Honolulu)</text>
<text class="r7" transform="matrix(1 0 0 1 49 504.6406)"><tspan x="0" y="0" font-family="Robot" font-size="11">Protein Sciences Corporation </tspan><tspan x="0" y="13.2" font-family="Robot" font-size="11">(Connecticut)</tspan></text>
<text class="r8" transform="matrix(1 0 0 1 48.998 558.665)" font-family="Robot" font-size="11">NewLinks Genetics (Iowa)</text>
<text class="r9" transform="matrix(1 0 0 1 48.998 606.8477)" font-family="Robot" font-size="11">PaxVax (California)</text>
<text class="r6" transform="matrix(1 0 0 1 272.5161 465.625)" font-family="Robot" font-size="11">USA</text>
<text class="r7" transform="matrix(1 0 0 1 272.5161 511.2402)" font-family="Robot" font-size="11">USA</text>
<text class="r8" transform="matrix(1 0 0 1 272.5161 558.665)" font-family="Robot" font-size="11">USA</text>
<text class="r9" transform="matrix(1 0 0 1 272.5161 606.8477)" font-family="Robot" font-size="11">USA</text>
<text class="r10" transform="matrix(1 0 0 1 272.5161 418.4648)" font-family="Robot" font-size="11">France</text>
<text class="r10" transform="matrix(1 0 0 1 396 418.4648)" font-family="Robot" font-size="11">Recombinant attenuated virus vaccine</text>
<text class="r6" textLength="360" transform="matrix(1 0 0 1 396 459.0244)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Non-replicative vaccines based on recombinant </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">viral subunits</tspan>
</text>
<text class="r7" textLength="300" transform="matrix(1 0 0 1 675 504.6406)">
  <tspan x="0" y="0" font-family="Robot" font-size="11">Clinical studies to start in </tspan>
  <tspan x="0" y="13.2" font-family="Robot" font-size="11">following months</tspan>
</text>
<text class="r7" transform="matrix(1 0 0 1 396 511.2402)" font-family="Robot" font-size="11">Recombinant protein vaccine</text>
<text class="r8" transform="matrix(1 0 0 1 675 558.665)" font-family="Robot" font-size="11">Unknown</text>
<text class="r8" transform="matrix(1 0 0 1 396 558.666)" font-family="Robot" font-size="11">Complete inactivated virus vaccine</text>
<text class="r9" transform="matrix(1 0 0 1 675 600.248)"><tspan x="0" y="0" font-family="Robot" font-size="11">Planning preclinical studies</tspan><tspan x="0" y="13.2" font-family="Robot" font-size="11"></tspan></text>
<text class="r9" transform="matrix(1 0 0 1 396 606.8486)" font-family="Robot" font-size="11">Virus like particles (VLP) vaccine</text>
<text class="r10"  transform="matrix(1 0 0 1 675 411.8643)">

  <tspan x="0" y="0" font-family="Robot" font-size="11">Planning clinical studies </tspan>
  <!-- <tspan x="0" y="13.2" font-family="Robot" font-size="11">cl√≠nicos en humanos</tspan> -->
</text>
<text transform="matrix(1 0 0 1 9.5654 645.0947)" font-family="Robot" font-style="italic" font-size="10">Source: based on data in E  Waltz. GM mosquitoes fire first salvo against Zika virus. Nature Biotechnologies.  March 2016</text>
<rect x="461" y="454.5" fill="none" width="4" height="16"/>
</svg>
